MM

Muniyappan Marimuthu

Active Director Director DIN 07056561
DIN 07056561 First appointment Jan 2015 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Muniyappan Marimuthu

Data last updated:

Muniyappan Marimuthu is a Director at Hapten Healthcare Private Limited (since 2015). The company operates in Business Services.

DIN 07056561
Primary Designation Director
Industry Business Services
First Appointment 12 Jan 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hapten Healthcare Private Limited U74900TN2015PTC098778
Director12 Jan 20152015Active

Board colleagues of Muniyappan Marimuthu

Directorship timeline

Open interactive timeline →
Hapten Healthcare Private Limited
Premium access

Shareholding and investment profile for Muniyappan Marimuthu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muniyappan Marimuthu

Muniyappan Marimuthu currently holds 1 directorship: Hapten Healthcare Private Limited (Director, since 12 Jan 2015).

Muniyappan Marimuthu was first appointed on 12 Jan 2015 as Director at Hapten Healthcare Private Limited.

The current boards of Muniyappan Marimuthu's companies include Gopal Prabakaran (Hapten Healthcare Private Limited), Kaliyappan Shankarlal (Hapten Healthcare Private Limited), Ponnaya Vaandaiyar Boominathan (Hapten Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available